Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

3.08
-0.0400-1.28%
Post-market: 3.120.0400+1.30%19:30 EDT
Volume:682.28K
Turnover:2.11M
Market Cap:256.90M
PE:-2.20
High:3.21
Open:3.15
Low:3.02
Close:3.12
52wk High:5.55
52wk Low:1.03
Shares:83.41M
Float Shares:49.56M
Volume Ratio:1.01
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:22.46
PE(LYR):-2.40

Loading ...

Pyxis Oncology files to sell 39.2M shares of common stock for holders

TIPRANKS
·
Aug 21

Pyxis Oncology Price Target Maintained with a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 18

Buy Rating Reiterated on Pyxis Ahead of Pivotal MICVO Phase 1 Readout; $7 Price Target Maintained

TIPRANKS
·
Aug 18

Buy Rating Reiterated on MICVO’s Differentiated Profile and 2026 Data Catalysts; $6 Price Target Maintained

TIPRANKS
·
Aug 15

Analysts Are Bullish on Top Healthcare Stocks: BridgeBio Pharma (BBIO), Pyxis Oncology (PYXS)

TIPRANKS
·
Aug 14

Pyxis Oncology (PYXS) Gets a Buy from Wells Fargo

TIPRANKS
·
Aug 14

Pyxis Oncology Faces Mounting Dilution Risk as Ongoing Equity Raises and Warrants Pressure Shareholder Value

TIPRANKS
·
Aug 14

Genelux Posts Wider-than-Expected Q2 Loss on Higher R&D Expenses

Reuters
·
Aug 14

NuCana Q2 Loss Narrows as Clinical Milestones Remain on Track

Reuters
·
Aug 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: Candel Therapeutics (CADL), LENSAR (LNSR) and Pyxis Oncology (PYXS)

TIPRANKS
·
Aug 14

U.S. Stocks on the MOVE-EnerSys, Netflix, Salesforce

Reuters
·
Aug 14

Pyxis Oncology Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Pyxis Oncology Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 13

Pyxis Oncology Posts Corporate Deck Spotlighting MICVO Extracellular-Targeting ADC in Head-and-Neck Cancer

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

Pyxis Oncology Q2 EPS $(0.40) Misses $(0.35) Estimate

Benzinga Earnings
·
Aug 13

Pyxis Oncology Q2 Net Income USD -25.346 Million

Reuters
·
Aug 13

Pyxis Oncology Q2 Operating Expenses USD 25.99 Million

THOMSON REUTERS
·
Aug 13

Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances Micvo Toward Key 2026 Clinical Milestones

THOMSON REUTERS
·
Aug 13

Press Release: Pyxis Oncology Reports Second Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones

Dow Jones
·
Aug 13